{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:42:00Z","timestamp":1784889720975,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11060-021-03711-z","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T22:01:19Z","timestamp":1613685679000},"page":"373-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study"],"prefix":"10.1007","volume":"152","author":[{"given":"Arbaz A.","family":"Momin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianning","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin S.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilyana","family":"Angelov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza M.","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene H.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo F.","family":"Recinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3217-8279","authenticated-orcid":false,"given":"Varun R.","family":"Kshettry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"3711_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/neuonc\/3.3.152","volume":"3","author":"FG Davis","year":"2001","unstructured":"Davis FG, Kupelian V, Freels S et al (2001) Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol 3:152\u2013158. https:\/\/doi.org\/10.1093\/neuonc\/3.3.152","journal-title":"Neuro Oncol"},{"key":"3711_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1227\/01.NEU.0000170980.47582.A5","volume":"57","author":"A Modha","year":"2005","unstructured":"Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538\u2013549. https:\/\/doi.org\/10.1227\/01.NEU.0000170980.47582.A5","journal-title":"Neurosurgery"},{"key":"3711_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11060-010-0343-1","volume":"99","author":"L Rogers","year":"2010","unstructured":"Rogers L, Gilbert M, Vogelbaum MA (2010) Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol 99:393\u2013405. https:\/\/doi.org\/10.1007\/s11060-010-0343-1","journal-title":"J Neurooncol"},{"key":"3711_CR4","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/neuonc\/nov069","volume":"17","author":"VR Kshettry","year":"2015","unstructured":"Kshettry VR, Ostrom QT, Kruchko C et al (2015) Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States. Neuro Oncol 17:1166\u20131173. https:\/\/doi.org\/10.1093\/neuonc\/nov069","journal-title":"Neuro Oncol"},{"key":"3711_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644","journal-title":"A RANO review. J Neurosurg"},{"key":"3711_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1227\/01.NEU.0000188281.91351.B9","volume":"57","author":"EB Claus","year":"2005","unstructured":"Claus EB, Bondy ML, Schildkraut JM et al (2005) Epidemiology of intracranial meningioma. Neurosurgery 57:1088\u20131094. https:\/\/doi.org\/10.1227\/01.NEU.0000188281.91351.B9","journal-title":"Neurosurgery"},{"key":"3711_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/FOC\/2008\/24\/5\/E3","volume":"24","author":"BE Pearson","year":"2008","unstructured":"Pearson BE, Markert JM, Fisher WS et al (2008) Hitting a moving target: Evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus 24:1\u20138. https:\/\/doi.org\/10.3171\/FOC\/2008\/24\/5\/E3","journal-title":"Neurosurg Focus"},{"key":"3711_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2990.2004.00621.x","volume":"31","author":"J Willis","year":"2005","unstructured":"Willis J, Smith C, Ironside JW et al (2005) The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol Appl Neurobiol 31:141\u2013149. https:\/\/doi.org\/10.1111\/j.1365-2990.2004.00621.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3711_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1227\/01.NEU.0000330399.55586.63","volume":"64","author":"MK Aghi","year":"2009","unstructured":"Aghi MK, Carter BS, Cosgrove GR et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56\u201360. https:\/\/doi.org\/10.1227\/01.NEU.0000330399.55586.63","journal-title":"Neurosurgery"},{"key":"3711_CR10","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00701-014-2156-z","volume":"156","author":"S Hammouche","year":"2014","unstructured":"Hammouche S, Clark S, Wong AHL et al (2014) Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir (Wien) 156:1475\u20131481. https:\/\/doi.org\/10.1007\/s00701-014-2156-z","journal-title":"Acta Neurochir (Wien)"},{"key":"3711_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep35743","volume":"6","author":"YC Wang","year":"2016","unstructured":"Wang YC, Chuang CC, Wei KC et al (2016) Long term surgical outcome and prognostic factors of atypical and malignant meningiomas. Sci Rep 6:1\u20138. https:\/\/doi.org\/10.1038\/srep35743","journal-title":"Sci Rep"},{"key":"3711_CR12","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3171\/2016.5.JNS152809","volume":"126","author":"HP Bagshaw","year":"2017","unstructured":"Bagshaw HP, Burt LM, Jensen RL et al (2017) Adjuvant radiotherapy for atypical meningiomas. J Neurosurg 126:1822\u20131828. https:\/\/doi.org\/10.3171\/2016.5.JNS152809","journal-title":"J Neurosurg"},{"key":"3711_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3171\/2011.5.JNS11112","volume":"115","author":"R Mair","year":"2011","unstructured":"Mair R, Morris K, Scott I et al (2011) Radiotherapy for atypical meningiomas: clinical article. J Neurosurg 115:811\u2013819. https:\/\/doi.org\/10.3171\/2011.5.JNS11112","journal-title":"J Neurosurg"},{"key":"3711_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3171\/2012.12.JNS12414","volume":"119","author":"DA Hardesty","year":"2013","unstructured":"Hardesty DA, Wolf AB, Brachman DG et al (2013) The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 119:475\u2013481. https:\/\/doi.org\/10.3171\/2012.12.JNS12414","journal-title":"J Neurosurg"},{"key":"3711_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1227\/neu.0000000000000461","volume":"75","author":"SQ Sun","year":"2014","unstructured":"Sun SQ, Kim AH, Cai C et al (2014) Management of atypical cranial meningiomas, Part 1. Neurosurgery 75:347\u2013355. https:\/\/doi.org\/10.1227\/neu.0000000000000461","journal-title":"Neurosurgery"},{"key":"3711_CR16","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jocn.2010.03.036","volume":"17","author":"K Jo","year":"2010","unstructured":"Jo K, Park HJ, Nam DH et al (2010) Treatment of atypical meningioma. J Clin Neurosci 17:1362\u20131366. https:\/\/doi.org\/10.1016\/j.jocn.2010.03.036","journal-title":"J Clin Neurosci"},{"key":"3711_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11060-018-2813-9","volume":"138","author":"WC Chen","year":"2018","unstructured":"Chen WC, Hara J, Magill ST et al (2018) Salvage therapy outcomes for atypical meningioma. J Neurooncol 138:425\u2013433. https:\/\/doi.org\/10.1007\/s11060-018-2813-9","journal-title":"J Neurooncol"},{"issue":"Suppl","key":"3711_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3171\/sup.2004.101.supplement3.0390","volume":"101","author":"DC Shrieve","year":"2004","unstructured":"Shrieve DC, Hazard L, Boucher K, Jensen RL (2004) Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg 101(Suppl):390\u2013395","journal-title":"J Neurosurg"},{"key":"3711_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1227\/NEU.0b013e3181f2f427","volume":"67","author":"CYH Choi","year":"2010","unstructured":"Choi CYH, Soltys SG, Gibbs IC et al (2010) Cyberknife stereotactic radiosurgery for treatment of atypical (Who Grade II) cranial meningiomas. Neurosurgery 67:1180\u20131188. https:\/\/doi.org\/10.1227\/NEU.0b013e3181f2f427","journal-title":"Neurosurgery"},{"key":"3711_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/cncr.26362","volume":"118","author":"BE Pollock","year":"2012","unstructured":"Pollock BE, Stafford SL, Link MJ et al (2012) Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. Cancer 118:1048\u20131054. https:\/\/doi.org\/10.1002\/cncr.26362","journal-title":"Cancer"},{"key":"3711_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/00006123-199803000-00002","volume":"42","author":"R Hakim","year":"1998","unstructured":"Hakim R, Alexander E, Loeffler JS et al (1998) Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery 42:446\u2013454. https:\/\/doi.org\/10.1097\/00006123-199803000-00002","journal-title":"Neurosurgery"},{"key":"3711_CR22","unstructured":"Stafford SL, Pollock BE, Foote RL, et al (2001) Meningioma radiosurgery: complications among 190 consecutive patients. Neurosurgery 49"},{"key":"3711_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0360-3016(95)02166-3","volume":"34","author":"MF Milosevic","year":"1996","unstructured":"Milosevic MF, Frost PJ, Laperriere NJ et al (1996) Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34:817\u2013822. https:\/\/doi.org\/10.1016\/0360-3016(95)02166-3","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3711_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11060-007-9338-y","volume":"84","author":"H Kano","year":"2007","unstructured":"Kano H, Takahashi JA, Katsuki T et al (2007) Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol 84:41\u201347. https:\/\/doi.org\/10.1007\/s11060-007-9338-y","journal-title":"J Neurooncol"},{"key":"3711_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","volume":"129","author":"L Rogers","year":"2018","unstructured":"Rogers L, Zhang P, Vogelbaum MA et al (2018) Intermediate-risk meningioma: Initial outcomes from NRG Oncology RTOG 0539. J Neurosurg 129:35\u201347. https:\/\/doi.org\/10.3171\/2016.11.JNS161170","journal-title":"J Neurosurg"},{"key":"3711_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1227\/NEU.0000000000001160","volume":"79","author":"SQ Sun","year":"2016","unstructured":"Sun SQ, Cai C, Murphy RKJ et al (2016) Radiation therapy for residual or recurrent atypical meningioma: The effects of modality, timing, and tumor pathology on long-term outcomes. Neurosurgery 79:23\u201332. https:\/\/doi.org\/10.1227\/NEU.0000000000001160","journal-title":"Neurosurgery"},{"key":"3711_CR27","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.12.020","volume":"71","author":"D Pasquier","year":"2008","unstructured":"Pasquier D, Bijmolt S, Veninga T et al (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. a multicenter, retrospective study of the rare cancer network. Int J Radiat Oncol Biol Phys 71:1388\u20131393. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.12.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3711_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1006434124794","volume":"48","author":"EB Hug","year":"2000","unstructured":"Hug EB, DeVries A, Thornton AF et al (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151\u2013160. https:\/\/doi.org\/10.1023\/A:1006434124794","journal-title":"J Neurooncol"},{"key":"3711_CR29","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3171\/2014.9.JNS14233","volume":"122","author":"R Aboukais","year":"2015","unstructured":"Aboukais R, Zairi F, Lejeune JP et al (2015) Grade 2 meningioma and radiosurgery. J Neurosurg 122:1157\u20131162. https:\/\/doi.org\/10.3171\/2014.9.JNS14233","journal-title":"J Neurosurg"},{"key":"3711_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0090-3019(03)00320-3","volume":"60","author":"AE Harris","year":"2003","unstructured":"Harris AE, Lee JYK, Omalu B et al (2003) The effect of radiosurgery during management of aggressive meningiomas. Surg Neurol 60:298\u2013305. https:\/\/doi.org\/10.1016\/S0090-3019(03)00320-3","journal-title":"Surg Neurol"},{"key":"3711_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.1994.80.2.0195","volume":"80","author":"BJ Goldsmith","year":"1994","unstructured":"Goldsmith BJ, Wara WM, Wilson CB, Larson DA (1994) Postoperative irradiation for subtotally resected meningiomas. a retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195\u2013201. https:\/\/doi.org\/10.3171\/jns.1994.80.2.0195","journal-title":"J Neurosurg"},{"key":"3711_CR32","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","volume":"106","author":"CL Rogers","year":"2020","unstructured":"Rogers CL, Won M, Vogelbaum MA et al (2020) High-risk meningioma: initial outcomes from NRG oncology\/RTOG 0539. Int J Radiat Oncol Biol Phys 106:790\u2013799. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3711_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ijrobp.2013.12.037","volume":"88","author":"RH Press","year":"2014","unstructured":"Press RH, Prabhu RS, Appin CL et al (2014) Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 88:1004\u20131010. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.12.037","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3711_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11060-012-0828-1","volume":"108","author":"A Attia","year":"2012","unstructured":"Attia A, Chan MD, Mott RT et al (2012) Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery. J Neurooncol 108:179\u2013185. https:\/\/doi.org\/10.1007\/s11060-012-0828-1","journal-title":"J Neurooncol"},{"key":"3711_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/COC.0000000000000008","volume":"38","author":"RA Sethi","year":"2015","unstructured":"Sethi RA, Rush SC, Liu S et al (2015) Dose-response relationships for meningioma radiosurgery. Am J Clin Oncol Cancer Clin Trials 38:600\u2013604. https:\/\/doi.org\/10.1097\/COC.0000000000000008","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"key":"3711_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11060-015-1770-9","volume":"123","author":"MW McDonald","year":"2015","unstructured":"McDonald MW, Plankenhorn DA, McMullen KP et al (2015) Proton therapy for atypical meningiomas. J Neurooncol 123:123\u2013128. https:\/\/doi.org\/10.1007\/s11060-015-1770-9","journal-title":"J Neurooncol"},{"key":"3711_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-018-03067-x","volume":"142","author":"VM Lu","year":"2019","unstructured":"Lu VM, Goyal A, Lee A et al (2019) The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis. J Neurooncol 142:1\u201310. https:\/\/doi.org\/10.1007\/s11060-018-03067-x","journal-title":"J Neurooncol"},{"key":"3711_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","volume":"140","author":"P Sievers","year":"2020","unstructured":"Sievers P, Hielscher T, Schrimpf D et al (2020) CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140:409\u2013413. https:\/\/doi.org\/10.1007\/s00401-020-02188-w","journal-title":"Acta Neuropathol"},{"key":"3711_CR39","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, Schrimpf D, Stichel D et al (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol 18:682\u2013694. https:\/\/doi.org\/10.1016\/S1470-2045(17)30155-9","journal-title":"Lancet Oncol"},{"key":"3711_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00401-017-1678-x","volume":"133","author":"A Olar","year":"2017","unstructured":"Olar A, Wani KM, Wilson CD et al (2017) Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol 133:431\u2013444. https:\/\/doi.org\/10.1007\/s00401-017-1678-x","journal-title":"Acta Neuropathol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-021-03711-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03711-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T14:35:31Z","timestamp":1616769331000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-021-03711-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3711"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03711-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Gene H. Barnett (consultant, Monteris Medical, Inc.), John Suh (consultant for NovoCure and Philips), Varun R. Kshettry (consultant, Integra).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}